carbamates has been researched along with alpha-synuclein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chamot-Rooke, J; Dautrey, S; Melki, R; Nury, C; Redeker, V; Renard, PY; Romieu, A; van der Rest, G | 1 |
| Cheng, SH; Clarke, J; Dodge, JC; Makino, E; Marshall, J; Olszewski, MA; Park, H; Richards, AM; Sardi, SP; Shihabuddin, LS; Sidman, RL; Treleaven, CM; Viel, C; Wang, B | 1 |
| Balakrishnan, R; Chandramohan, V; Elangovan, N; Hunday, G; Jayaraj, RL; Kumaradhas, P; Lalithamba, HS; Manimaran, D; Mohankumar, T; Sivanandam, M; Vijayakumar, R | 1 |
3 other study(ies) available for carbamates and alpha-synuclein
| Article | Year |
|---|---|
A novel bio-orthogonal cross-linker for improved protein/protein interaction analysis.
Topics: alpha-Synuclein; Amino Acid Sequence; Azides; Carbamates; Chromatography, Liquid; Cross-Linking Reagents; HSC70 Heat-Shock Proteins; Humans; Mass Spectrometry; Models, Molecular; Molecular Sequence Data; Parkinson Disease; Protein Interaction Mapping; Protein Interaction Maps | 2015 |
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models.
Topics: alpha-Synuclein; Animals; Carbamates; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Glucosyltransferases; Humans; Mice; Mutation; Parkinson Disease; Protein Aggregation, Pathological; Quinuclidines; tau Proteins; Ubiquitin | 2017 |
Design and Molecular dynamic Investigations of 7,8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein.
Topics: alpha-Synuclein; Carbamates; Computer Simulation; Drug Design; Esters; Flavones; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure | 2020 |